Provided by Tiger Trade Technology Pte. Ltd.

Edwards Lifesciences

85.19
-1.1300-1.31%
Post-market: 85.190.00000.00%19:38 EDT
Volume:3.08M
Turnover:263.04M
Market Cap:49.12B
PE:49.56
High:86.84
Open:85.99
Low:84.49
Close:86.32
52wk High:96.29
52wk Low:72.30
Shares:576.54M
Float Shares:575.03M
Volume Ratio:0.81
T/O Rate:0.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.72
EPS(LYR):1.83
ROE:9.18%
ROA:8.37%
PB:4.63
PE(LYR):46.48

Loading ...

Edwards Lifesciences, Genesis Medtech to Pay Combined $12M to Settle FTC Charges

Dow Jones
·
Jul 14

Edwards Lifesciences is Maintained at Outperform by RBC Capital

Dow Jones
·
Jul 13

RBC Raises Price Target on Edwards Lifesciences to $110 From $100, Keeps Outperform Rating

MT Newswires Live
·
Jul 13

Edwards Lifesciences CVP Daniel J. Lippis Disposes of 619 Common Shares Worth $56,762.3

Reuters
·
Jul 11

Edwards Lifesciences Corp. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 09

Citigroup Adjusts Edwards Lifesciences Price Target to $110 From $101

MT Newswires Live
·
Jul 08

Edwards Lifesciences is Maintained at Buy by Citigroup

Dow Jones
·
Jul 08

Edwards Lifesciences price target raised to $110 from $101 at Citi

TIPRANKS
·
Jul 08

Citi Keeps Their Buy Rating on Edwards Lifesciences (EW)

TIPRANKS
·
Jul 08

HII is Assessed “Awardable” in the U.S. Department of War CDAO Tradewinds Solutions Marketplace

GlobeNewswire
·
Jul 07

Edwards Lifesciences is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Jul 07

Evercore ISI Adjusts Price Target on Edwards Lifesciences to $100 From $93

MT Newswires Live
·
Jul 06

Carvolix Says Edwards Lifesciences Holding Lifts Stake to 11.65% of Capital, 9.07% Voting Rights

Reuters
·
Jul 06

Edwards Lifesciences Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 02

Edwards Lifesciences CVP Daniel J. Lippis Disposes of Common Shares Worth $56,596.72

Reuters
·
Jul 01

Edwards Lifesciences is Maintained at Buy by BTIG

Dow Jones
·
Jun 30

VisionWave Signs Definitive Agreement to Acquire Controlling Interest in Meteor Aerospace

GlobeNewswire
·
Jun 30

BTIG Keeps Their Buy Rating on Edwards Lifesciences (EW)

TIPRANKS
·
Jun 30

BTIG Adjusts Price Target on Edwards Lifesciences to $110 From $100, Maintains Buy Rating

MT Newswires Live
·
Jun 30

Edwards Lifesciences Secures US FDA Approval for Ecliptis System

MT Newswires Live
·
Jun 30